Cyclophosphamide/Prednisolone/Rituximab/Vinblastine Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide, vinblastine, prednisolone and rituximab that may be used in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).

**Synonyms:** - CVbP + Rituximab Regimen - CVbP Plus Rituximab Regimen - Cyclophosphamide-Prednisolone-Rituximab-Vinblastine - Cyclophosphamide-Prednisolone-Rituximab-Vinblastine Regimen - Cyclophosphamide/Prednisolone/Rituximab/Vinblastine - Cyclophosphamide/Vinblastine/Prednisolone Plus Rituximab Regimen - Cytoxan/Prednisolone/Rituxan/Vinblastine